-
Taxonomy & unit
-
ratio: %
-
Description
-
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
-
Summary
-
Lyell Immunopharma, Inc. quarterly/annual Operating Margin history and growth rate from Q4 2021 to Q2 2025.
- Lyell Immunopharma, Inc. Operating Margin for the quarter ending June 30, 2025 was -594K %, a 42.1% decline year-over-year.
- Lyell Immunopharma, Inc. annual Operating Margin for 2024 was -588K %, a 210% decline from 2023.
- Lyell Immunopharma, Inc. annual Operating Margin for 2023 was -190K %, a 85918% decline from 2022.
- Lyell Immunopharma, Inc. annual Operating Margin for 2022 was -221 %, a 89% increase from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)